首页> 美国卫生研究院文献>Frontiers in Neuroscience >Does Sex/Gender Play a Role in Placebo and Nocebo Effects? Conflicting Evidence From Clinical Trials and Experimental Studies
【2h】

Does Sex/Gender Play a Role in Placebo and Nocebo Effects? Conflicting Evidence From Clinical Trials and Experimental Studies

机译:性别/性别是否在安慰剂和Nocebo效应中起作用?来自临床试验和实验研究的证据相互矛盾

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sex has been speculated to be a predictor of the placebo and nocebo effect for many years, but whether this holds true or not has rarely been investigated. We utilized a placebo literature database on various aspects of the genuine placebo/nocebo response. In 2015, we had extracted 75 systematic reviews, meta-analyses, and meta-regressions performed in major medical areas (neurology, psychiatry, internal medicine). These meta-analyses were screened for whether sex/gender differences had been noted to contribute to the placebo/nocebo effect: in only 3 such analyses female sex was associated with a higher placebo effect, indicating poor evidence for a contribution of sex to it in RCTs. This was updated with another set of meta-analyses for the current review, but did not change the overall conclusion. The same holds true for 18 meta-analyses investigating adverse event (nocebo) reporting in RCT in the placebo arm of trials. We also screened our database for papers referring to sex/gender and the placebo effect in experimental studies, and identified 28 papers reporting 29 experiments. Their results can be summarized as follows: (a) Despite higher sensitivity of pain in females, placebo analgesia is easier to elicit in males; (b) It appears that conditioning is effective specifically eliciting nocebo effects; (c) Conditioning works specifically well to elicit placebo and nocebo effects in females and with nausea; (d) Verbal suggestions are not sufficient to induce analgesia in women, but work in men. These results will be discussed with respect to the question why nausea and pain may be prone to be responsive to sex/gender differences, while other symptoms are less. Lastly, we will discuss the apparent discrepancy between RCT with low relevance of sex, and higher relevance of sex in specific experimental settings. We argue that the placebo response is predominantly the result of a conditioning (learning) response in females, while in males it predominantly may be generated via (verbal) manipulating of expectancies. In RCT therefore, the net outcome of the intervention may be the same despite different mechanisms generating the placebo effect between the sexes, while in experimental work when both pathways are separated and explicitly explored, such differences may surface.
机译:多年来,人们一直认为性别是安慰剂和Nocebo效应的预测因子,但是很少能证实这种效应是否成立。我们利用了有关真正安慰剂/ nocebo反应各个方面的安慰剂文献数据库。 2015年,我们提取了在主要医学领域(神经病学,精神病学,内科医学)进行的75项系统评价,荟萃分析和荟萃回归。筛选了这些荟萃分析,以确定是否注意到性别/性别差异会导致安慰剂/ nocebo效应:仅在3次此类分析中,女性与较高的安慰剂效应相关,表明缺乏证据表明性别对其有贡献。 RCT。本次审查对本研究进行了另一组荟萃分析,但并未改变总体结论。在18个荟萃分析中,研究安慰剂组在RCT中报告不良事件(nocebo)的情况也是如此。我们还筛选了数据库,以查找涉及实验研究中涉及性别/性别和安慰剂效应的论文,并确定了28篇报告29项实验的论文。他们的结果可归纳如下:(a)尽管女性对疼痛的敏感性更高,但男性更容易引起安慰剂镇痛; (b)调理似乎有效地引起了诺西波效应; (c)调理作用特别好,以引起女性和恶心的安慰剂和诺西博作用; (d)口头建议不足以引起女性的镇痛作用,但在男性中起作用。这些结果将针对为什么恶心和疼痛可能对性别差异做出反应而其他症状较少的问题进行讨论。最后,我们将讨论在特定的实验环境中,性别相关性较低的RCT与性别相关性较高的明显差异。我们认为,安慰剂反应主要是女性的条件(学习)反应的结果,而在男性中,安慰剂反应主要是通过对预期的(口头)操纵而产生的。因此,在RCT中,尽管产生性别间安慰剂作用的机制不同,但干预的最终结果可能是相同的,而在实验工作中,当两种途径被分开并明确探索时,这种差异可能会浮出水面。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号